ABBV vs AMGN — Key Metrics
| Metric | ABBV (ABBVIE INC) | AMGN (AMGEN INC) |
|---|---|---|
| Price | 261.59 | 421.51 |
| Market Cap | 462.26 Billion | 227.88 Billion |
| P/E (TTM) | 73.69 | 25.99 |
| P/B (Quarterly) | -72.404 | 18.864 |
| P/S (TTM) | 7.18 | 5.98 |
| Net Profit Margin (TTM) | 9.8 | 23.0 |
| Gross Margin (TTM) | 71.5 | 69.5 |
| ROE (TTM) | -135.7 | 89.3 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
ABBV · ABBVIE INC
Outperform
AMGN · AMGEN INC
Outperform
Recommendation Summary
Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: AMGN.
Financial Metrics
Prices delayed ~15 min
| ABBV | Metrics | AMGN |
|---|---|---|
| $261.59 | Price | $421.51 |
| — | Market Capitalization | — |
| 73.69 | Price to Earnings Ratio | 25.99 |
| 7.18 | Price to Sales | 5.98 |
| 25.38 | Price to FCF Ratio | 22.4 |
| 10.04 | Price to Gross Profit | 8.61 |
| 47.59 | Price to R&D | 29.87 |
| 13.73 | Price to Current Assets | 6.52 |